Effects of Sideritis scardica Extract on Glucose Tolerance, Triglyceride Levels and Markers of Oxidative Stress in Ovariectomized Rats

Abstract

Menopause is characterized by deep metabolic disturbances, including decreased insulin sensitivity, adiposity, and changes in lipid profiles. Estrogen replacement therapy can partially reverse these changes, and while it is safe in most healthy postmenopausal women, there are still existing concerns regarding an increased risk for breast and endometrial cancer as well as a risk for cardiovascular and thromboembolic disease. Therefore, certain natural compounds with positive metabolic effects may be considered as a possible alternative or adjunctive treatment in patients not willing to take estrogens or patients with contraindications for estrogens. The aim of this study was to investigate the influence of Sideritis scardica (mountain tea) extract on metabolic disturbances induced by ovariectomy in rats. The study included 24 rats divided into three groups: ovariectomized rats treated with 200 mg/kg S. scardica extract for 24 weeks (n = 8), ovariectomized non-treated (n = 8), and Sham-operated (n = 8) rats. Food intake, weight gain, body composition, fasting glucose levels, response to oral glucose challenge, liver glycogen content, catalase activity, thiol groups, and malondialdehyde concentrations as well as AMP-activated protein kinase activity in liver cells were studied. Ovariectomized rats treated with S. scardica extract had lower blood triglycerides, reduced fasting glucose levels, as well lower glucose peaks after oral glucose challenge, increased liver glycogen content, and significantly higher catalase activity and thiol group concentration than non-treated ovariectomized rats. The ability of S. scardica extract to attenuate metabolic disturbances associated with ovariectomy was associated with the activation of AMP-activated protein kinase in liver cells.

Key words

Sideritis scardica - Lamiaceae - menopause - ovariectomy - metabolic disturbance - AMPK

• References

• 1 Godsland IF. Oestrogens and insulin secretion. Diabetologia 2005; 48: 2213-2220
• 2 Lizcano F, Guzmán G. Estrogen deficiency and the origin of obesity during menopause. Biomed Res Int 2014; 2014: 757461
• 3 Castelao JE, Gago-Dominguez M. Risk factors for cardiovascular disease in women: relationship to lipid peroxidation and oxidative stress. Med Hypotheses 2008; 71: 39-44
• 4 Ohlsson C, Hellberg N, Parini P, Vidal O, Bohlooly YM, Rudling M, Lindberg MK, Warner M, Angelin B, Gustafsson JA. Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochem Biophys Res Commun 2000; 278: 640-645
• 5 Villa P, Sagnella F, Perri C, Suriano R, Costantini B, Macrí F, Ricciardi L, Lanzone A. Low- and standard-estrogen dosage in oral therapy: dose-dependent effects on insulin and lipid metabolism in healthy postmenopausal women. Climacteric 2008; 11: 498-508
• 6 Signorelli SS, Neri S, Sciacchitano S, Pino LD, Costa MP, Marchese G, Celotta G, Cassibba N, Pennisi G, Caschetto S. Behaviour of some indicators of oxidative stress in postmenopausal and fertile women. Maturitas 2006; 53: 77-82
• 7 Sassarini J, Lumsden MA. Oestrogen replacement in postmenopausal women. Age Ageing 2015; 44: 551-558
• 8 Poluzzi E, Piccinni C, Raschi E, Rampa A, Recanatini M, De Ponti F. Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective. Curr Med Chem 2014; 21: 417-436
• 9 Kassi E, Papoutsi Z, Fokialakis N, Messari I, Mitakou S, Moutsatsou P. Greek plant extracts exhibit selective estrogen receptor modulator (SERM)-like properties. J Agric Food Chem 2004; 52: 6956-6961
• 10 Dontas IA, Lelovas PP, Kourkoulis SK, Aligiannis N, Paliogianni A, Mitakou S, Galanos A, Kassi E, Mitousoudis A, Xanthos TT, Papaioannou N, Lyritis GP. Protective effect of Sideritis euboea extract on bone mineral density and strength of ovariectomized rats. Menopause 2011; 18: 915-922
• 11 Jeremic I, Tadic V, Isakovic A, Trajkovic V, Markovic I, Redzic Z, Isakovic A. The mechanisms of in vitro cytotoxicity of mountain tea, Sideritis scardica, against the C6 glioma cell line. Planta Med 2013; 79: 1516-1524
• 12 Coughlan KA, Valentine RJ, Ruderman NB, Saha AK. AMPK activation: a therapeutic target for type 2 diabetes?. Diabetes Metab Syndr Obes 2014; 7: 241-253
• 13 Stark R, Ashley SE, Andrews ZB. AMPK and the neuroendocrine regulation of appetite and energy expenditure. Mol Cell Endocrino 2013; 366: 215-223
• 14 Moreno FN, Campos-Shimada LB, da Costa SC, Garcia RF, Cecchini AL, Natali MR, Vitoriano Ade S, Ishii-Iwamoto EL, Salgueiro-Pagadigorria CL. Vitex agnus-castus L. (Verbenaceae) improves the liver lipid metabolism and redox state of ovariectomized rats. Evid Based Complement Alternat Med 2015; 2015: 212378
• 15 Musatov S, Chen W, Pfaff DW, Mobbs CV, Yang XJ, Clegg DJ, Kaplitt MG, Ogawa S. Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proc Natl Acad Sci U S A 2007; 104: 2501-2506
• 16 Minokoshi Y, Shiuchi T, Lee S, Suzuki A, Okamoto S. Role of hypothalamic AMP-kinase in food intake regulation. Nutrition 2008; 24: 786-790
• 17 Bertoia LM, Rimm EB, Mukamal KJ, Hu FB, Willett WC, Cassidy A. Dietary flavonoid intake and weight maintenance: three prospective cohorts of 124,086 US men and women followed for up to 24 years. BMJ 2016; 352: i17
• 18 Zimmet P, Baba S. Central obesity, glucose intolerance and other cardiovascular disease risk factors: an old syndrome rediscovered. Diabetes Res Clin Pract 1990; 10: S167-S171
• 19 Jeon SM. Regulation and function of AMPK in physiology and diseases. Exp Mol Med 2016; 48: e245
• 20 Egan B, Zierath JR. Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab 2013; 17: 162-184
• 21 Casanova G, Bossardi Ramos R, Ziegelmann P, Spritzer PM. Effects of low-dose versus placebo or conventional-dose postmenopausal hormone therapy on variables related to cardiovascular risk: a systematic review and meta-analyses of randomized clinical trials. J Clin Endocrinol Metab 2015; 100: 1028-1037
• 22 Kahn BB, Alquier T, Carling D, Hardie DG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 2005; 1: 15-25
• 23 Barton M, Prossnitz ER. Emerging roles of GPER in diabetes and atherosclerosis. Trends Endocrinol Metab 2015; 26: 185-192
• 24 Pereira DF, Cazarolli LH, Lavado C, Mengatto V, Figueiredo MS, Guedes A, Pizzolatti MG, Silva FR. Effects of flavonoids on α-glucosidase activity: potential targets for glucose homeostasis. Nutrition 2011; 27: 1161-1167
• 25 Huang Y, Cai X, Chen P, Mai W, Tang H, Huang Y, Hu Y. Associations of prediabetes with all-cause and cardiovascular mortality: a meta-analysis. Ann Med 2014; 46: 684-692
• 26 Beckett T, Tchernof A, Toth MJ. Effect of ovariectomy and estradiol replacement on skeletal muscle enzyme activity in female rats. Metabolism 2002; 51: 1397-1401
• 27 Hunter RW, Treebak JT, Wojtaszewski JFP, Sakamoto K. Molecular mechanism by which AMP-activated protein kinase activation promotes glycogen accumulation in muscle. Diabetes 2011; 60: 766-774
• 28 Holmes BF, Kurth-Kraczek EJ, Winder WW. Chronic activation of 5′-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. J Appl Physiol 1999; 87: 1990-1995
• 29 Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes 2015; 6: 456-480
• 30 Ogunro PS, Bolarinde AA, Owa OO, Salawu AA, Oshodi AA. Antioxidant status and reproductive hormones in women during reproductive, perimenopausal and postmenopausal phase of life. Afr J Med Med Sci 2014; 43: 49-57
• 31 Bellanti F, Matteo M, Rollo T, De Rosario F, Greco P, Vendemiale G, Serviddio G. Sex hormones modulate circulating antioxidant enzymes: impact of estrogen therapy. Redox Biol 2013; 1: 340-346
• 32 Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PA. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 2001; 74: 418-425
• 33 Sid B, Verrax J, Calderon PB. Role of AMPK activation in oxidative cell damage: Implications for alcohol-induced liver disease. Biochem Pharmacol 2013; 86: 200-209
• 34 Velioglu YS, Mazza G, Gao L, Oomah BD. Antioxidant activity and total phenolics in selected fruits, vegetables, and grain products. J Agric Food Chem 1998; 46: 4113-4117
• 35 Petronijevic N, Sopta J, Doknic M, Radonjic N, Petronijevic M, Pekic S, Maric N, Jasovic-Gasic M, Popovic V. Chronic risperidone exposure does not show any evidence of bone mass deterioration in animal model of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2013; 46: 58-63
• 36 Duncombe WG. The colorimetric micro-deterination of non-esterified fatty acids in plasma. Clin Chim Acta 1964; 9: 122-125
• 37 Rehncrona S, Smith DS, Akesson B, Westerberg E, Siesjö BK. Peroxidative changes in brain cortical fatty acids and phospholipids, as characterized during Fe²⁺ and ascorbic acid stimulated lipid peroxidation in vitro . J Neurochem 1980; 34: 1630-1638
• 38 Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellmanʼs reagent. Anal Biochem 1968; 25: 192-205
• 39 Góth L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta 1991; 196: 143-151